Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Plus Therapeutics - 24 Year Stock Price History | PSTV

Historical daily share price chart and data for Plus Therapeutics since 2001 adjusted for splits and dividends. The latest closing stock price for Plus Therapeutics as of May 29, 2025 is 0.29.
  • The all-time high Plus Therapeutics stock closing price was 1000000.00 on November 11, 2005.
  • The Plus Therapeutics 52-week high stock price is 2.67, which is 820.7% above the current share price.
  • The Plus Therapeutics 52-week low stock price is 0.24, which is 17.2% below the current share price.
  • The average Plus Therapeutics stock price for the last 52 weeks is 1.27.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Plus Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.9219 1.1800 1.5700 0.2700 0.2864 -75.10%
2024 1.6851 1.8500 2.6000 0.9900 1.1500 -34.29%
2023 3.2082 4.6500 7.2000 1.0100 1.7500 -63.54%
2022 10.1056 16.3500 19.8000 4.5000 4.8000 -69.52%
2021 32.4524 31.6500 56.2500 15.4500 15.7500 -48.02%
2020 32.6496 39.7500 47.5500 15.7500 30.3000 -15.83%
2019 149.1429 240.0000 292.5000 29.8500 36.0000 -83.45%
2018 1318.1175 2175.0000 3750.0000 202.5000 217.5000 -90.33%
2017 6779.8805 12000.0000 14925.0000 1725.0000 2250.0000 -80.13%
2016 18043.7500 21375.0000 39375.0000 10200.0000 11325.0000 -47.02%
2015 65593.7500 58500.0000 154125.0000 21375.0000 21375.0000 -61.22%
2014 206080.3571 283500.0000 373500.0000 42750.0000 55125.0000 -80.93%
2013 284066.9643 319500.0000 376875.0000 231750.0000 289125.0000 -8.21%
2012 340681.5000 256500.0000 534375.0000 228375.0000 315000.0000 27.27%
2011 526084.8214 606375.0000 928125.0000 221625.0000 247500.0000 -57.61%
2010 588619.0476 699750.0000 1000000.0000 383625.0000 583875.0000 -14.92%
2009 390647.3214 405000.0000 739125.0000 175500.0000 686250.0000 68.98%
2008 604405.1383 687375.0000 963000.0000 212625.0000 406125.0000 -40.33%
2007 640801.7928 720000.0000 745875.0000 523125.0000 680625.0000 -7.49%
2006 724109.5618 931500.0000 1000000.0000 451125.0000 735750.0000 -21.20%
2005 509188.9881 267750.0000 1000000.0000 258750.0000 933750.0000 201.82%
2004 380107.1429 343125.0000 506250.0000 281250.0000 309375.0000 -9.84%
2003 400209.8214 450000.0000 502875.0000 326250.0000 343125.0000 -23.75%
2002 418138.3929 378000.0000 562500.0000 309375.0000 450000.0000 25.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.005B $0.006B
Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.007B 31.89
Zoetis (ZTS) United States $73.637B 27.48
Daiichi Sankyo, - (DSNKY) Japan $51.945B 26.43
Takeda Pharmaceutical (TAK) Japan $46.424B 9.23
Sandoz Group AG (SDZNY) Switzerland $21.498B 0.00
Summit Therapeutics (SMMT) United States $19.339B 0.00
Merck (MKKGY) Germany $16.886B 12.37
United Therapeutics (UTHR) United States $14.237B 12.60
Shionogi (SGIOY) Japan $13.900B 13.93
Neurocrine Biosciences (NBIX) United States $12.176B 41.71
IPSEN (IPSEY) France $9.821B 0.00
Orion OYJ (ORINY) Finland $9.318B 25.20
Corcept Therapeutics (CORT) United States $8.234B 66.94
Stevanato Group S.p.A (STVN) Italy $7.023B 42.94
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.014B 0.00
Grifols, S.A (GRFS) Spain $5.624B 0.00
Ionis Pharmaceuticals (IONS) United States $5.162B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.818B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.993B 10.49
Crinetics Pharmaceuticals (CRNX) United States $2.800B 0.00
Hypermarcas (HYPMY) Brazil $2.707B 17.81
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.260B 12.22
BioCryst Pharmaceuticals (BCRX) United States $2.210B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.943B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.787B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.730B 0.00
Indivior (INDV) United States $1.660B 7.04
ARS Pharmaceuticals (SPRY) United States $1.458B 0.00
Evotec AG (EVO) Germany $1.406B 0.00
Guardian Pharmacy Services (GRDN) United States $1.358B 0.00
Dyne Therapeutics (DYN) United States $1.337B 0.00
Ocular Therapeutix (OCUL) United States $1.257B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.078B 21.57
Harrow (HROW) United States $0.951B 0.00
Ardelyx (ARDX) United States $0.935B 0.00
Collegium Pharmaceutical (COLL) United States $0.929B 5.01
Avadel Pharmaceuticals (AVDL) Ireland $0.875B 0.00
Enliven Therapeutics (ELVN) United States $0.789B 0.00
Cronos Group (CRON) Canada $0.779B 0.00
Akebia Therapeutics (AKBA) United States $0.756B 0.00
Xeris Biopharma Holdings (XERS) United States $0.748B 0.00
AleAnna (ANNA) United States $0.601B 0.00
Elite Pharmaceuticals (ELTP) United States $0.575B 0.00
KalVista Pharmaceuticals (KALV) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.553B 12.02
Regulus Therapeutics (RGLS) United States $0.549B 0.00
Xencor (XNCR) United States $0.537B 0.00
Bioventus (BVS) United States $0.536B 13.60
Relay Therapeutics (RLAY) United States $0.506B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.458B 0.00
Zevra Therapeutics (ZVRA) United States $0.455B 0.00
Altimmune (ALT) United States $0.445B 0.00
Siga Technologies (SIGA) United States $0.435B 9.09
Oruka Therapeutics (ORKA) United States $0.429B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.427B 0.00
CytoDyn (CYDY) United States $0.421B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Verve Therapeutics (VERV) United States $0.378B 0.00
Savara (SVRA) United States $0.369B 0.00
Organogenesis (ORGO) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.343B 9.27
Heron Therapeutics (HRTX) United States $0.279B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
Aquestive Therapeutics (AQST) United States $0.271B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.88
MediWound (MDWD) Israel $0.228B 0.00
ProKidney (PROK) United States $0.207B 0.00
Nanobiotix S.A (NBTX) France $0.189B 0.00
Journey Medical (DERM) United States $0.183B 0.00
Wellgistics Health (WGRX) United States $0.167B 0.00
Esperion Therapeutics (ESPR) United States $0.165B 0.00
Avita Medical (RCEL) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
4D Molecular Therapeutics (FDMT) United States $0.161B 0.00
OmniAb (OABI) United States $0.158B 0.00
Profound Medical (PROF) Canada $0.157B 0.00
Aclaris Therapeutics (ACRS) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.152B 0.00
Aldeyra Therapeutics (ALDX) United States $0.133B 0.00
Nektar Therapeutics (NKTR) United States $0.130B 0.00
Larimar Therapeutics (LRMR) United States $0.127B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Liminatus Pharma (LIMN) $0.119B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
Cardiol Therapeutics (CRDL) Canada $0.106B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.096B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Lexeo Therapeutics (LXEO) United States $0.091B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 64.89
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Inotiv (NOTV) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.59
Galectin Therapeutics (GALT) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Surrozen (SRZN) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Rafael Holdings (RFL) United States $0.032B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
PolyPid (PYPD) Israel $0.026B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
SHINECO (SISI) China $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.88
Talphera (TLPH) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Aditxt (ADTX) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00